Fulcrum Therapeutics, Inc. (FULC)

Last Closing Price: 6.59 (2026-05-21)

Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Fulcrum Therapeutics, Inc. (FULC) Cost of Goods Sold data is not available.

Figures for fiscal quarter ending 2026-03-31
Income Statement Financials
--
$-18.89M
Cost of Goods Sold
--
--
$22.19M
$-22.19M
$3.29M
$-18.89M
$-18.89M
$-18.89M
$-18.89M
$-18.89M
$-18.89M
$-22.19M
$-21.85M
76.22M
76.22M
$-0.25
$-0.25
Balance Sheet Financials
$338.67M
$2.49M
$8.10M
$346.77M
$9.86M
--
$3.60M
$13.47M
$333.30M
$333.30M
$333.30M
66.61M
Cash Flow Statement Financials
$-18.75M
$-128.21M
$-0.31M
$198.73M
$51.46M
$-147.27M
$3.86M
--
--
Fundamental Metrics & Ratios
34.33
--
--
--
--
--
--
--
--
--
--
$-18.76M
--
--
--
--
--
--
--
-5.67%
-5.67%
-5.45%
-5.67%
$5.00
$-0.25
$-0.25